JDD Article Highlight Could targeting the JAK/STAT pathway redefine how we approach cutaneous lupus erythematosus (CLE)? Spanning acute (ACLE), subacute (SCLE), and chronic (CCLE) forms, CLE presents a spectrum of…
JDD Article Highlight Hyaluronic acid (HA) fillers are widely used in cosmetic dermatology, but delayed immunologic reactions (DIRs) remain a rare yet important complication. While common triggers like infections are…
JDD Online Exclusive With rising antibiotic resistance and acne symptoms varying widely, how can dermatologists uncover the ideal solution for each patient? Emerging approaches aim to balance skin care, targeted…
JDD Latest News Could injectable minoxidil revolutionize hair loss management? While widely used in topical and oral forms, its injectable counterpart is garnering attention for treating conditions like androgenetic alopecia and…
JDD Online Exclusive As new psoriasis treatments expand, so do potential side effects like oral candidiasis. This common yet manageable condition may present with distinctive symptoms, such as burning sensations or…
JDD Article Highlights The launch of the Health Care Administration Leadership and Management (HALM) subspecialty in 2023 is poised to redefine leadership in dermatology. Supported by the American Board of…
JDD Article Highlights Cutaneous collagenous vasculopathy (CCV), a rare microangiopathy affecting the lower extremities, lacks a well-defined treatment. However, case reports suggest vascular laser therapy may reduce CCV-associated telangiectasias. In…
2024 JDD Welcome Kit The Journal of Drugs in Dermatology (JDD) and its sponsors are welcoming the latest dermatology residency graduates into the specialty. Graduates from 2024 are each receiving…
JDD Article Highlights From teledermatology to total body photography, digital advancements have reshaped dermatology—but often at a steep cost. Could the widespread adoption of LiDAR technology on smartphones change that?…
JDD Article Highlights Dermatology thrives on visuals, making it a natural fit for social media. Yet, most dermatology-related content online isn’t from board-certified dermatologists. How can the specialty take charge?…
JDD Article Highlights Scarring alopecia, marked by irreversible hair follicle damage, is notoriously difficult to treat. While immunomodulatory therapies are the cornerstone, emerging evidence suggests platelet-rich plasma (PRP) may help…
JDD Article Highlights Lentigo maligna (LM) and its more invasive form, lentigo maligna melanoma (LMM), are increasingly on dermatologists' radar, especially for elderly patients with sun-damaged skin. Historically, the treatment…